Biogen Archives - Pharmaphorum

R&D roundup – Sage impresses at JP Morgan

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-sage-impresses-at-jp-morgan/

Pair of deals boosts Biogen’s early-stage CNS pipeline

https://pharmaphorum.com/news/pair-of-deals-boosts-biogens-early-stage-cns-pipeline/

Roche’s SMA drug gets PRIME regulatory status in Europe

https://pharmaphorum.com/news/roches-sma-drug-gets-prime-regulatory-status-in-europe/

Alkermes/Biogen hope for less tummy trouble with new MS pill

https://pharmaphorum.com/news/alkermes-biogen-hope-for-less-tummy-trouble-with-new-ms-pill/

NHS saving £300m with Humira biosimilar deal

https://pharmaphorum.com/news/nhs-saving-300m-with-humira-biosimilar-deal/

Merck KGaA’s BTK drug reduces lesions in relapsing MS patients

https://pharmaphorum.com/news/merck-kgaas-btk-drug-reduces-lesions-in-relapsing-ms-patients/

NICE in talks with Biogen after rejecting SMA drug

https://pharmaphorum.com/news/nice-in-talks-with-biogen-after-rejecting-sma-drug/

Biogen and Eisai Alzheimer’s drug excites doctors, but not investors

https://pharmaphorum.com/news/biogen-and-eisai-alzheimers-drug-excites-doctors-but-not-investors/

PureTech to research Alzheimer’s drugs based on ‘brain drain’ theory

https://pharmaphorum.com/news/puretech-research-alzheimers-brain-drain-theory/

Search